13F-HR/A filed by Logos Global Management LP
Logos Global Management LP filed this 13F-HR/A for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-19 19:52:47 UTC, with 75 holding rows worth $1,918,698,941.
- Accession
- 0001172661-26-005476
- Filer
- CIK 1792126
- Filed
- 2026-11-19
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, amendment of type restatement, 75 entries on the cover page, a total value of $1,918,698,941 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,918,698,941 with VALUE read as dollars as filed, 13F file number 028-20025. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 425,000 | $123,772,750 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 600,000 | $123,156,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,850,000 | $109,497,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,900,000 | $86,494,000 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 870,000 | $86,147,400 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 975,000 | $69,117,750 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 1,015,000 | $66,441,900 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 650,000 | $63,895,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 2,150,000 | $53,642,500 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,000 | $50,396,000 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,080,000 | $49,507,200 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 3,000,000 | $48,330,000 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 5,951,032 | $48,143,849 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 6,000,000 | $46,020,000 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 500,000 | $44,025,000 | dollars as filed | |
| ARRIVENT BIOPHARMA INC | 04272N102 | COM | 1,350,000 | $40,878,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,250,000 | $40,025,000 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,500,000 | $36,650,000 | dollars as filed | call |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 250,000 | $35,460,000 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 200,000 | $33,964,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 175,000 | $32,268,250 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,000,000 | $31,270,000 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 3,208,875 | $27,724,680 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 935,000 | $25,413,300 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 750,000 | $24,217,500 | dollars as filed | |
| APNIMED INC | 03770Y107 | COM | 1,100,000 | $24,101,000 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 1,026,258 | $23,111,330 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 1,500,000 | $22,995,000 | dollars as filed | call |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,445,000 | $20,692,400 | dollars as filed | |
| VERADERMICS INC | 922967104 | COMMON STOCK | 170,000 | $20,609,100 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,500,000 | $19,860,000 | dollars as filed | call |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 600,000 | $19,374,000 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,500,000 | $18,855,000 | dollars as filed | call |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 846,148 | $18,801,409 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,000,000 | $18,220,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 1,000,000 | $18,220,000 | dollars as filed | call |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 1,500,000 | $17,550,000 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 1,000,000 | $16,910,000 | dollars as filed | call |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 500,000 | $15,145,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,100,000 | $14,685,000 | dollars as filed | |
| Obsidian Therapeutics, Inc. | 67448A106 | Common Stock, $0.0001 par value per share | 1,066,212 | $14,639,091 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 250,000 | $13,830,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,000,000 | $13,350,000 | dollars as filed | call |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 350,000 | $13,321,000 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 500,000 | $12,915,000 | dollars as filed | call |
| ENTERA BIO LTD | M40527109 | SHS | 4,411,764 | $12,838,233 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 1,000,000 | $12,570,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,000,000 | $12,440,000 | dollars as filed | call |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 850,000 | $12,401,500 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 1,000,000 | $11,250,000 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 3,288,777 | $11,017,403 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 250,000 | $9,595,000 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 1,000,000 | $8,090,000 | dollars as filed | call |
| ALUMIS INC | 022307102 | COM | 1,000,000 | $7,390,000 | dollars as filed | call |
| INVENTIVA SA | 46124U107 | ADS | 2,000,000 | $7,380,000 | dollars as filed | call |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 391,426 | $6,709,042 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 2,000,000 | $6,540,000 | dollars as filed | call |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 200,000 | $6,520,000 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 2,222,000 | $5,710,540 | dollars as filed | |
| TONIX PHARMACEUTICALS HOLDIN | 890260839 | COMMON STOCK | 550,000 | $5,357,000 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 1,000,000 | $4,840,000 | dollars as filed | |
| VOGENX INC | 92859A106 | COM | 205,000 | $4,671,950 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 85,000 | $2,871,300 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 200,000 | $2,810,000 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 963,855 | $2,626,505 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 200,000 | $2,502,000 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y202 | COMMON STOCK | 473,563 | $2,223,378 | dollars as filed | |
| PALATIN TECHNOLOGIES INC | 696077601 | COM NEW | 129,260 | $1,146,536 | dollars as filed | |
| JATT II ACQUISITION CORP | G50765109 | ORD SHS | 100,000 | $1,124,500 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 100,000 | $1,102,000 | dollars as filed | |
| Research Alliance Corp Iii Ord Shs Cl A | G75226103 | Common Stock | 100,000 | $1,083,000 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 23,548 | $921,433 | dollars as filed | |
| AMANAT ACQUISITION CORP | G0375M101 | CL A ORD | 50,000 | $534,000 | dollars as filed | |
| Longeveron Inc | 54303L302 | COM | 192,308 | $517,309 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 504,965 | $274,903 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-005128 | superseded | 2026-11-16 | ||
| 13F-HR/A 0001172661-26-005476 | this filing | 2026-11-19 |